Effect Comparison of Metformin and Repaglinide in the Treatment of Elderly Diabetic Patients
- VernacularTitle:二甲双胍与瑞格列奈治疗老年糖尿病患者疗效比较
- Author:
Chunxia ZHOU
;
Waner WU
- Publication Type:Journal Article
- Keywords:
Metformin;
Repaglinide;
Elderly diabetes;
Efficacy
- From:
China Pharmacist
2014;(5):837-838,839
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy and safety of metformin in the treatment of elderly patients with diabetes. Meth-ods:Totally 72 cases of elderly patients with diabetes in our hospital from January 2012 to December 2012 were randomly divided into the observation group and the control group. The observation group was received metformin, and the control group was given repaglin-ide. The efficacy and safety of the two groups were compared. Results:After the treatment, blood sugar of fasting, 2h after meals and 10:00 p. m. in the observation group and the control group was significantly decreased (P<0. 05), and blood sugar of fasting in the observation group was significantly lower than that in the control (P<0. 05), while that of the other time points was without significant difference (P>0. 05). The HbA1c levels before and after the treatment in the observation group was with statistically significant differ-ence (P<0. 05), and those in the control group was without significant difference (P>0. 05). The incidence of adverse reactions in the observation group was lower than that in the control group(P<0. 05). Conclusion:Effect of metformin in the treatment of elderly patients with diabetes is remarkable and safe, which is worthy of further promotion and application.
